BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4986543)

  • 21. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic plasmapheresis in treatment of patients with Waldenström's macroglobulinemia.
    Lawson NS; Nosanchuk JS; Oberman HA; Meyers MC
    Transfusion; 1968; 8(3):174-8. PubMed ID: 4968993
    [No Abstract]   [Full Text] [Related]  

  • 23. Waldenström's macroglobulinemia.
    Johnson SA
    Rev Clin Exp Hematol; 2002 Dec; 6(4):421-34; discussion 449-50. PubMed ID: 12823781
    [No Abstract]   [Full Text] [Related]  

  • 24. Advances in the biology and treatment of Waldenström's macroglobulinemia: a report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, Sweden.
    Treon SP; Patterson CJ; Kimby E; Stone MJ
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):10-5. PubMed ID: 19362961
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bilateral occlusion of the central vein of the retina disclosing Waldenström's disease].
    Nabet L; Dufier JL; Cornu P; Junghers P; Chauvin JC; de Monteynard MS; Manderieux N; Haye C
    Bull Soc Ophtalmol Fr; 1989 Jan; 89(1):39-41. PubMed ID: 2513133
    [No Abstract]   [Full Text] [Related]  

  • 26. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
    Amin CJ; Rabinowitz I
    Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late report of the first case of plasmapheresis for Waldenström's Macroglobulinemia.
    Reynolds WA
    JAMA; 1981 Feb; 245(6):606-7. PubMed ID: 6779021
    [No Abstract]   [Full Text] [Related]  

  • 28. [Waldenström's disease with pulmonary involvement].
    Baldus M; Stark M; Klooker P; Schleiffer T; Brass H
    Med Klin (Munich); 1992 Aug; 87(8):437-40. PubMed ID: 1406478
    [No Abstract]   [Full Text] [Related]  

  • 29. Waldenstrom's macrogloblinaemia: modified plasmapheresis as treatment option in a Nigeria setting.
    Abjah UM; Aken'Ova YA; Ocheni S
    Niger J Med; 2002; 11(4):190-2. PubMed ID: 12955999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Waldenstrom's macroglobulinemia, its clinical aspects. Observations on 4 confirmed cases].
    Freigang K
    Med Welt; 1966 Sep; 39():2053-9. PubMed ID: 4958554
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström's macroglobulinemia.
    Somer T; Ditzel J
    Bibl Haematol; 1981; (47):242-6. PubMed ID: 6802129
    [No Abstract]   [Full Text] [Related]  

  • 32. [Waldenström's macroglobulinemia--a clinical analysis of five cases].
    Chiu ZH; Ho CH; Chong LL
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Feb; 3(2):91-8. PubMed ID: 3129579
    [No Abstract]   [Full Text] [Related]  

  • 33. Case report: bilateral simultaneous central retinal vein occlusion in Waldenström's macroglobulinemia.
    Chanana B; Gupta N; Azad RV
    Optometry; 2009 Jul; 80(7):350-3. PubMed ID: 19545847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Secondary biochemical syndrome and IgM hypermacroglobulinemia in Waldenström's disease].
    Mebazaa A; Ollier MP; Degrelle H; Lazar P; Filitti-Wurmser S; Hartmann L
    Ann Biol Clin (Paris); 1970; 28(1):25-40. PubMed ID: 4986988
    [No Abstract]   [Full Text] [Related]  

  • 36. How we treat Waldenström's macroglobulinemia.
    Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
    Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstrom's macroglobulinemia.
    Caravita T; Siniscalchi A; Tendas A; Cupelli L; Dentamaro T; Natale G; Spagnoli A; de Fabritiis P
    Bone Marrow Transplant; 2009 Apr; 43(7):587-8. PubMed ID: 18978819
    [No Abstract]   [Full Text] [Related]  

  • 38. High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
    Anagnostopoulos A; Dimopoulos MA; Aleman A; Weber D; Alexanian R; Champlin R; Giralt S
    Bone Marrow Transplant; 2001 May; 27(10):1027-9. PubMed ID: 11438816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in treatment of multiple myeloma and Waldenström's macroglobulinemia.
    Alexanian R; Weber D
    Biomed Pharmacother; 2001 Nov; 55(9-10):550-2. PubMed ID: 11769965
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypervolemia in Waldenström's macroglobulinemia].
    Herreman G; Piguet H; Zittoun R; Bilski-Pasquier G; Bousser J
    Nouv Rev Fr Hematol; 1968; 8(2):209-26. PubMed ID: 4232366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.